Clinical trial
Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
NCT00263484 · Gleneagles Hospital, Other · Completed
Key facts
| NCT number | NCT00263484 |
|---|---|
| Title | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma |
| Official title | An International, Multicenter, Non-Randomized, Open-Labeled Study to Evaluate the Efficacy of Lower Dose Dexamethasone/Thalidomide and Higher Frequency ZOMETA(TM) in the Treatment of Previously Untreated Patients With Multiple Myeloma |
| Acronym | dtZ |
| Lead sponsor | Gleneagles Hospital, Other |
| Collaborators | Singapore General Hospital National Cancer Centre, Singapore Tan Tock Seng Hospital Seoul National University Hospital Asan Medical Center Samsung Medical Center Chonnam National University Hospital… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | dexamethasone, thalidomide, zoledronic acid |
| Enrollment | 56 |
| Start date | Dec 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2010 |
| First posted | Dec 8, 2005 |
| Last update posted | Jul 21, 2011 |
| Countries | India, Singapore, South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: